A recent study led by doctoral student Rebekah Maynard at the University of Georgia explores the use of controlled environment agriculture (CEA) to cultivate crops with medicinal properties, particularly focusing on the production of apigenin, a natural anti-inflammatory compound with anti-cancer potential. The research involved growing chamomile and parsley in a vertical farming setup to assess how different environmental factors influence the concentration of apigenin. Results indicated that while the ‘Giant of Italy’ parsley cultivar produced the largest plants, the ‘Bodegold’ chamomile yielded a higher total accumulation of apigenin, along with more usable biomass. The study suggests that optimizing growth conditions, such as incorporating UV light, could enhance apigenin production, thereby increasing the feasibility and profitability of vertical farming for biopharmaceutical applications. This highlights the potential for year-round production of valuable medicinal compounds in controlled environments, which is becoming increasingly relevant as investment in vertical farming technology grows nationwide.